Propyl paraben

What this is

Under current U.S. federal rules, propyl paraben is still an FDA-recognized food ingredient for antimicrobial use, with food use limited by good manufacturing practice and a stated current maximum of 0.1%. FDA has also placed propylparaben on its post-market risk-and-safety review list, with review initiated in 2024. The main safety debate is reproductive/endocrine relevance: EFSA could not include propyl paraben in the methyl/ethyl paraben group ADI in 2004, and JECFA withdrew its ADI in 2006 because male-rat reproductive findings lacked a clear no-effect level. Later peer-reviewed reviews argue those original findings were not robust and that subsequent rat studies did not reproduce male reproductive toxicity at much higher doses. Regulators therefore disagree: the U.S. still permits limited food uses, while the EU removed E216/E217 from food-additive authorization and several U.S. states have enacted broad retail-food restrictions or bans.

Safety Review

The health areas reviewed when evaluating an ingredient. This does not mean the ingredient is proven to cause harm.

FDA still permits limited food use and is reviewing propylparaben, but EFSA could not include it in the methyl/ethyl paraben group ADI and JECFA withdrew its ADI after male-rat reproductive findings. Later reviews report the original findings were not reproduced at higher doses, so reproductive concern remains unresolved rather than proven human harm.